NEU.AX Current Ratio

As of 2025-05-24, the Current Ratio of Neuren Pharmaceuticals Ltd (NEU.AX) is 8.73.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

NEU.AX Current Ratio - Historical Value

Date	Value
2024-12-31	8.73
2023-12-31	5.78
2022-12-31	25.77
2021-12-31	49.87
2020-12-31	33.12
2019-12-31	25.75
2018-12-31	13.5
2017-12-31	10.18
2016-12-31	2.99
2015-12-31	6.67

NEU.AX Current Ratio - Peers Comparison

Ticker	Name	Value
204840.KQ	GL Pharm Tech Corp	1.37
4586.T	Medrx Co Ltd	19.63
AC8.AX	Auscann Group Holdings Ltd	49.47
ACR.AX	Acrux Ltd	4.14
AGH.AX	Althea Group Holdings Ltd	0.64
ANP.AX	Antisense Therapeutics Ltd	4.51
AVE.AX	Avecho Biotechnology Ltd	2.81
BOT.AX	Botanix Pharmaceuticals Ltd	22.21
CAN.AX	Cann Group Ltd	0.21
CGB.AX	Cann Global Ltd	2.95
CP1.AX	CANNPAL ANIMAL THERAPEUTICS ORD	5.82
ECS.AX	ECS Botanics Holdings Ltd	5.07
IDT.AX	IDT Australia Ltd	1.34
IVX.AX	Invion Ltd	18.7
IXC.AX	Invex Therapeutics Ltd	14.18
LGP.AX	Little Green Pharma Ltd	3.34
MXC.AX	MGC Pharmaceuticals Ltd	0.19
NYR.AX	Nyrada Inc	25.35
PAA.AX	Neurizon Therapeutics Ltd	12.42
PXS.AX	Pharmaxis Ltd	2.33
RCE.AX	Recce Pharmaceuticals Ltd	0.34
RNO.AX	Rhinomed Ltd	0.27
SPL.AX	Starpharma Holdings Ltd	4.94
VLS.AX	Vita Life Sciences Ltd	3.06
WFL.AX	Wellfully Ltd	0.58
ZLD.AX	Zelira Therapeutics Ltd	0.6